Clinical Trials Directory

Trials / Unknown

UnknownNCT03849235

A Pathophysiological Study of the Postprandial Human Liver (PLS)

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Copenhagen University Hospital, Hvidovre · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Fatty liver disease is a globally widespread disease The identification of valid biomarkers and targets for potential treatments requires in-depth knowledge about the pathophysiology of the postprandial liver. The study will consist of five work packages (WP) including blood tests and liver biopsies taken after fasting or ingestion of a standardized meal in: healthy controls (WP 1), patients with NAFLD (WP 2), and patients with cirrhosis (WP 3) ; before and after a standardised meal in healthy controls (WP 4), and before and after glucagon in healthy controls (WP5)

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStandardised meal or glucagonStandardised meal (Nutridrink, Nutricia, 300 kcal, 18.4 g carbohydrates, 5.8 g fat, 12 g protein) or 1mg glucagon

Timeline

Start date
2019-03-02
Primary completion
2022-01-01
Completion
2025-01-01
First posted
2019-02-21
Last updated
2021-01-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03849235. Inclusion in this directory is not an endorsement.

A Pathophysiological Study of the Postprandial Human Liver (PLS) (NCT03849235) · Clinical Trials Directory